SB 1630 - This act requires the Department of Health and Senior Services to designate non-communicable diseases that are of public health concern and enforce adequate orders, findings, rules, and regulations to prevent the spread of such diseases and to determine the prevalence of such diseases within the state. The Department shall include in its list of non-communicable diseases that are required to be reported to the Department alpha-gal syndrome and Lyme disease. Health care providers shall report any required non-communicable disease cases to the Department within 7 days of receiving a positive laboratory confirmation, while laboratories that finalize positive alpha-gal syndrome results shall be the entity that reports the results to the Department within that time period, as specified in the act. The Department shall follow up on reported cases of alpha-gal syndrome and shall submit an annual report to the Centers for Disease Control and Prevention on the reporting and incidence of alpha-gal syndrome and Lyme disease in Missouri. This act is identical to HB 1855 (2026). SARAH HASKINS

2026 Regular Session Introduced by Mary Elizabeth Coleman

Missouri bill establishes state disease reporting requirements for non-communicable conditions, expanding public health surveillance beyond infectious diseases with potential privacy and provider compliance implications.

Second Read and Referred S Families, Seniors and Health Committee

Legislative bill overview

SB 1630 establishes new reporting procedures for certain non-communicable diseases in Missouri. The bill creates a framework for healthcare providers and public health entities to report specific chronic conditions to state health authorities. This represents an expansion of Missouri's disease surveillance system, which traditionally focused on communicable (infectious) diseases.

Why is this important

Non-communicable diseases like heart disease, diabetes, and cancer account for the majority of deaths and healthcare costs in the U.S. Systematic reporting could help Missouri's Department of Health and Senior Services track disease burden, identify health disparities, and allocate public health resources more effectively. However, this also represents a significant shift in how Missouri monitors population health and collects medical data.

Potential points of contention

Privacy concerns: Expanding disease reporting requirements raises questions about patient privacy, data security, and whether individuals will be notified their conditions are being reported to the state

Healthcare provider burden: New reporting mandates increase administrative and compliance costs for doctors, hospitals, and clinics, potentially affecting smaller practices disproportionately

Scope and specificity: The bill's language doesn't clearly specify which non-communicable diseases trigger reporting requirements, leaving uncertainty about implementation and consistency across providers